News and Announcements
Top 5 Sectors In Australia For Investing
- Published December 20, 2022 2:22AM UTC
- Publisher Leila Oliveira
- Categories Capital Raising Tips
FIVE sectors together got almost 50% of the 10B dollars invested in Australian companies in 2021. 😵
Here’s a breakdown:
1. FinTech $2.5B (25% of the total)
2. Enterprise/Business Software $970M (10% of the total)
3. PropTech/ RealTech/ Construction $683M (7% of the total)
4. MarTech/ EdTech/ SalesTech $672M (7% of the total)
5. BioTech/ MedTech $573M (6% of the total)
Unsurprisingly, Blockchain/Crypto/Web3 startups saw the largest percentage gain in deal count – $227M in 20 deals in 2021, up from just one in 2020.
Other smaller but fast-growing sectors of note included Marketplaces (36x 2021 vs 9x 2020), Social Networking/Media (23x 2021 vs 8x 2020), and DevTech/Developer Tools (14x 2021 vs 7x 2020).
[data from The state of Australian Startup Funding 2021]
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
